{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:11:03Z","timestamp":1790748663522,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Prevention and Control of Geriatric Diseases in 2018","award":["2018135809-2"],"award-info":[{"award-number":["2018135809-2"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s13577-020-00430-x","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T03:03:39Z","timestamp":1610075019000},"page":"325-334","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["SH2 domain-containing protein tyrosine phosphatase-2 (SHP-2) prevents cardiac remodeling after myocardial infarction through ERK\/SMAD signaling pathway"],"prefix":"10.1007","volume":"34","author":[{"given":"Yong-Gang","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Lei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Qing","family":"Tie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,8]]},"reference":[{"issue":"9\u201310","key":"430_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.lfs.2010.06.013","volume":"87","author":"M Khan","year":"2010","unstructured":"Khan M, Kwiatkowski P, Rivera BK, Kuppusamy P. Oxygen and oxygenation in stem-cell therapy for myocardial infarction. Life Sci. 2010;87(9\u201310):269\u201374.","journal-title":"Life Sci"},{"issue":"6","key":"430_CR2","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1161\/hypertensionaha.117.09791","volume":"70","author":"E Mart\u00ednez-Mart\u00ednez","year":"2017","unstructured":"Mart\u00ednez-Mart\u00ednez E, Buonafine M, Boukhalfa I, Ibarrola J, Fern\u00e1ndez-Celis A, Kolkhof P, et al. Aldosterone target NGAL (Neutrophil Gelatinase-Associated Lipocalin) is involved in cardiac remodeling after myocardial infarction through NF\u03baB pathway. Hypertension (Dallas, Tex: 1979). 2017;70(6):1148\u201356. https:\/\/doi.org\/10.1161\/hypertensionaha.117.09791.","journal-title":"Hypertension (Dallas, Tex: 1979)."},{"issue":"5","key":"430_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nrcardio.2014.28","volume":"11","author":"NG Frangogiannis","year":"2014","unstructured":"Frangogiannis NG. The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol. 2014;11(5):255\u201365. https:\/\/doi.org\/10.1038\/nrcardio.2014.28.","journal-title":"Nat Rev Cardiol"},{"issue":"9","key":"430_CR4","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1111\/bph.14155","volume":"175","author":"S Huang","year":"2018","unstructured":"Huang S, Frangogiannis NG. Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges. Br J Pharmacol. 2018;175(9):1377\u2013400. https:\/\/doi.org\/10.1111\/bph.14155.","journal-title":"Br J Pharmacol"},{"issue":"Suppl 1","key":"430_CR5","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.21037\/jtd.2016.11.19","volume":"9","author":"NG Frangogiannis","year":"2017","unstructured":"Frangogiannis NG. The role of transforming growth factor (TGF)-\u03b2 in the infarcted myocardium. J Thorac Dis. 2017;9(Suppl 1):S52\u2013s63. https:\/\/doi.org\/10.21037\/jtd.2016.11.19.","journal-title":"J Thorac Dis"},{"issue":"1","key":"430_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms12260","volume":"7","author":"O Kanisicak","year":"2016","unstructured":"Kanisicak O, Khalil H, Ivey MJ, Karch J, Maliken BD, Correll RN, et al. Genetic lineage tracing defines myofibroblast origin and function in the injured heart. Nat Commun. 2016;7(1):1\u201314.","journal-title":"Nat Commun"},{"issue":"7","key":"430_CR7","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1172\/jci74783","volume":"124","author":"T Moore-Morris","year":"2014","unstructured":"Moore-Morris T, Guimar\u00e3es-Camboa N, Banerjee I, Zambon AC, Kisseleva T, Velayoudon A, et al. Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis. J Clin Investig. 2014;124(7):2921\u201334. https:\/\/doi.org\/10.1172\/jci74783.","journal-title":"J Clin Investig"},{"issue":"1","key":"430_CR8","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1038\/s41598-017-03234-6","volume":"7","author":"Y Liu","year":"2017","unstructured":"Liu Y, Baumgardt SL, Fang J, Shi Y, Qiao S, Bosnjak ZJ, et al. Transgenic overexpression of GTP cyclohydrolase 1 in cardiomyocytes ameliorates post-infarction cardiac remodeling. Sci Rep. 2017;7(1):3093. https:\/\/doi.org\/10.1038\/s41598-017-03234-6.","journal-title":"Sci Rep"},{"issue":"8","key":"430_CR9","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1016\/j.bbadis.2016.11.004","volume":"1863","author":"J Hu","year":"2017","unstructured":"Hu J, Zhang L, Zhao Z, Zhang M, Lin J, Wang J, et al. OSM mitigates post-infarction cardiac remodeling and dysfunction by up-regulating autophagy through Mst1 suppression. Biochim Biophys Acta. 2017;1863(8):1951\u201361. https:\/\/doi.org\/10.1016\/j.bbadis.2016.11.004.","journal-title":"Biochim Biophys Acta"},{"key":"430_CR10","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.3389\/fimmu.2019.02468","volume":"10","author":"C Niogret","year":"2019","unstructured":"Niogret C, Birchmeier W, Guarda G. SHP-2 in lymphocytes' cytokine and inhibitory receptor signaling. Front Immunol. 2019;10:2468. https:\/\/doi.org\/10.3389\/fimmu.2019.02468.","journal-title":"Front Immunol"},{"issue":"suppl_1","key":"430_CR11","first-page":"S20-S","volume":"109","author":"A Tzouvelekis","year":"2016","unstructured":"Tzouvelekis A, Yu G, Herazo-maya J, Xylourgidis N, Herzog E, Bennett A, et al. SH2 domain-containing phosphatase-SHP-2 is a novel regulator of fibroblast homeostasis in Pulmonary Fibrosis. QJM. 2016;109(suppl_1):S20-S.","journal-title":"QJM"},{"issue":"6","key":"430_CR12","doi-asserted-by":"publisher","first-page":"e21058","DOI":"10.1371\/journal.pone.0021058","volume":"6","author":"X Liu","year":"2011","unstructured":"Liu X, Li Y, Zhang Y, Lu Y, Guo W, Liu P, et al. SHP-2 promotes the maturation of oligodendrocyte precursor cells through Akt and ERK1\/2 signaling in vitro. PLoS ONE. 2011;6(6):e21058. https:\/\/doi.org\/10.1371\/journal.pone.0021058.","journal-title":"PLoS ONE"},{"issue":"Pt 1","key":"430_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1242\/jcs.076505","volume":"124","author":"B Bandyopadhyay","year":"2011","unstructured":"Bandyopadhyay B, Han A, Dai J, Fan J, Li Y, Chen M, et al. TbetaRI\/Alk5-independent TbetaRII signaling to ERK1\/2 in human skin cells according to distinct levels of TbetaRII expression. J Cell Sci. 2011;124(Pt 1):19\u201324. https:\/\/doi.org\/10.1242\/jcs.076505.","journal-title":"J Cell Sci"},{"issue":"9","key":"430_CR14","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1248\/bpb.28.1707","volume":"28","author":"M Otsuka","year":"2005","unstructured":"Otsuka M, Goto K, Tsuchiya S, Aramaki Y. Phosphatidylserine-specific receptor contributes to TGF-beta production in macrophages through a MAP kinase. ERK Biol Pharm Bull. 2005;28(9):1707\u201310. https:\/\/doi.org\/10.1248\/bpb.28.1707.","journal-title":"ERK Biol Pharm Bull"},{"issue":"3","key":"430_CR15","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1006\/jmcc.1998.0902","volume":"31","author":"J Hao","year":"1999","unstructured":"Hao J, Ju H, Zhao S, Junaid A, Scammell-La Fleur T, Dixon IM. Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing. J Mol Cell Cardiol. 1999;31(3):667\u201378. https:\/\/doi.org\/10.1006\/jmcc.1998.0902.","journal-title":"J Mol Cell Cardiol"},{"key":"430_CR16","doi-asserted-by":"publisher","first-page":"424652","DOI":"10.1155\/2014\/424652","volume":"2014","author":"JC Odekerken","year":"2014","unstructured":"Odekerken JC, Walenkamp GH, Brans BT, Welting TJ, Arts JJ. The longitudinal assessment of osteomyelitis development by molecular imaging in a rabbit model. Biomed Res Int. 2014;2014:424652. https:\/\/doi.org\/10.1155\/2014\/424652.","journal-title":"Biomed Res Int"},{"issue":"2","key":"430_CR17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1055\/s-0029-1214167","volume":"23","author":"M Patel","year":"2009","unstructured":"Patel M, Rojavin Y, Jamali AA, Wasielewski SJ, Salgado CJ. Animal models for the study of osteomyelitis. Semin Plast Surg. 2009;23(2):148\u201354. https:\/\/doi.org\/10.1055\/s-0029-1214167.","journal-title":"Semin Plast Surg"},{"issue":"1","key":"430_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1254\/jphs.fp0050966","volume":"101","author":"D Nishiya","year":"2006","unstructured":"Nishiya D, Omura T, Shimada K, Matsumoto R, Kusuyama T, Enomoto S, et al. Effects of erythropoietin on cardiac remodeling after myocardial infarction. J Pharmacol Sci. 2006;101(1):31\u20139. https:\/\/doi.org\/10.1254\/jphs.fp0050966.","journal-title":"J Pharmacol Sci"},{"issue":"3","key":"430_CR19","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1159\/000478641","volume":"42","author":"S Shen","year":"2017","unstructured":"Shen S, Jiang H, Bei Y, Zhang J, Zhang H, Zhu H, et al. Qiliqiangxin attenuates adverse cardiac remodeling after myocardial infarction in ovariectomized mice via activation of PPAR\u03b3. Cell Physiol Biochem. 2017;42(3):876\u201388. https:\/\/doi.org\/10.1159\/000478641.","journal-title":"Cell Physiol Biochem"},{"issue":"5","key":"430_CR20","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3109\/08977194.2011.595714","volume":"29","author":"A Biernacka","year":"2011","unstructured":"Biernacka A, Dobaczewski M, Frangogiannis NG. TGF-\u03b2 signaling in fibrosis. Growth Fact (Chur, Switzerland). 2011;29(5):196\u2013202. https:\/\/doi.org\/10.3109\/08977194.2011.595714.","journal-title":"Growth Fact (Chur, Switzerland)"},{"issue":"14","key":"430_CR21","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1093\/emboj\/cdf366","volume":"21","author":"L Yu","year":"2002","unstructured":"Yu L, H\u00e9bert MC, Zhang YE. TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO J. 2002;21(14):3749\u201359. https:\/\/doi.org\/10.1093\/emboj\/cdf366.","journal-title":"EMBO J"},{"key":"430_CR22","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1146\/annurev.biochem.67.1.753","volume":"67","author":"J Massagu\u00e9","year":"1998","unstructured":"Massagu\u00e9 J. TGF-beta signal transduction. Annu Rev Biochem. 1998;67:753\u201391. https:\/\/doi.org\/10.1146\/annurev.biochem.67.1.753.","journal-title":"Annu Rev Biochem"},{"issue":"8","key":"430_CR23","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1016\/j.jid.2018.02.036","volume":"138","author":"YN Im","year":"2018","unstructured":"Im YN, Lee YD, Park JS, Kim HK, Im SY, Song HR, et al. GPCR Kinase (GRK)-2 is a key negative regulator of itch: l-glutamine attenuates itch via a rapid induction of GRK2 in an ERK-dependent way. J Invest Dermatol. 2018;138(8):1834\u201342. https:\/\/doi.org\/10.1016\/j.jid.2018.02.036.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"430_CR24","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1038\/s41467-018-05768-3","volume":"9","author":"A Zehender","year":"2018","unstructured":"Zehender A, Huang J, Gy\u00f6rfi AH, Matei AE, Trinh-Minh T, Xu X, et al. The tyrosine phosphatase SHP2 controls TGF\u03b2-induced STAT3 signaling to regulate fibroblast activation and fibrosis. Nat Commun. 2018;9(1):3259. https:\/\/doi.org\/10.1038\/s41467-018-05768-3.","journal-title":"Nat Commun"},{"issue":"12","key":"430_CR25","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1111\/febs.13665","volume":"283","author":"I Fabregat","year":"2016","unstructured":"Fabregat I, Moreno-C\u00e0ceres J, S\u00e1nchez A, Dooley S, Dewidar B, Giannelli G, et al. TGF-\u03b2 signalling and liver disease. FEBS J. 2016;283(12):2219\u201332. https:\/\/doi.org\/10.1111\/febs.13665.","journal-title":"FEBS J"},{"key":"430_CR26","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.nbd.2013.01.005","volume":"54","author":"C Fiorentini","year":"2013","unstructured":"Fiorentini C, Savoia P, Savoldi D, Barbon A, Missale C. Persistent activation of the D1R\/Shp-2\/Erk1\/2 pathway in l-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's disease. Neurobiol Dise. 2013;54:339\u201348. https:\/\/doi.org\/10.1016\/j.nbd.2013.01.005.","journal-title":"Neurobiol Dise"},{"issue":"6","key":"430_CR27","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/s0962-8924(03)00104-1","volume":"13","author":"M Ros\u00e1rio","year":"2003","unstructured":"Ros\u00e1rio M, Birchmeier W. How to make tubes: signaling by the Met receptor tyrosine kinase. Trends Cell Biol. 2003;13(6):328\u201335. https:\/\/doi.org\/10.1016\/s0962-8924(03)00104-1.","journal-title":"Trends Cell Biol"},{"issue":"2","key":"430_CR28","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/jcp.10446","volume":"199","author":"C Ivins Zito","year":"2004","unstructured":"Ivins Zito C, Kontaridis MI, Fornaro M, Feng GS, Bennett AM. SHP-2 regulates the phosphatidylinositide 3'-kinase\/Akt pathway and suppresses caspase 3-mediated apoptosis. J Cell Physiol. 2004;199(2):227\u201336. https:\/\/doi.org\/10.1002\/jcp.10446.","journal-title":"J Cell Physiol"},{"issue":"1","key":"430_CR29","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12872-018-0816-2","volume":"18","author":"J Chen","year":"2018","unstructured":"Chen J, Cao Z, Guan J. SHP2 inhibitor PHPS1 protects against atherosclerosis by inhibiting smooth muscle cell proliferation. BMC Cardiovasc Disord. 2018;18(1):72. https:\/\/doi.org\/10.1186\/s12872-018-0816-2.","journal-title":"BMC Cardiovasc Disord"},{"issue":"3","key":"430_CR30","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.it.2006.01.007","volume":"27","author":"RJ Salmond","year":"2006","unstructured":"Salmond RJ, Alexander DR. SHP2 forecast for the immune system: fog gradually clearing. Trends Immunol. 2006;27(3):154\u201360. https:\/\/doi.org\/10.1016\/j.it.2006.01.007.","journal-title":"Trends Immunol"},{"issue":"6","key":"430_CR31","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1084\/jem.20112741","volume":"209","author":"T Yokosuka","year":"2012","unstructured":"Yokosuka T, Takamatsu M, Kobayashi-Imanishi W, Hashimoto-Tane A, Azuma M, Saito T. Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2. J Exp Med. 2012;209(6):1201\u201317. https:\/\/doi.org\/10.1084\/jem.20112741.","journal-title":"J Exp Med"},{"issue":"Pt 2","key":"430_CR32","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1042\/bj20020935","volume":"370","author":"AC Zannettino","year":"2003","unstructured":"Zannettino AC, Roubelakis M, Welldon KJ, Jackson DE, Simmons PJ, Bendall LJ, et al. Novel mesenchymal and haematopoietic cell isoforms of the SHP-2 docking receptor, PZR: identification, molecular cloning and effects on cell migration. Biochem J. 2003;370(Pt 2):537\u201349. https:\/\/doi.org\/10.1042\/bj20020935.","journal-title":"Biochem J"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-020-00430-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13577-020-00430-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-020-00430-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T18:06:14Z","timestamp":1614017174000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13577-020-00430-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,8]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["430"],"URL":"https:\/\/doi.org\/10.1007\/s13577-020-00430-x","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,8]]},"assertion":[{"value":"23 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal experiments were performed in accordance with the guidelines for animal care and the experimental protocols were approved by the Institutional Animal Care and Use Committee of our hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}